BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36591660)

  • 1. PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy.
    Li XY; Chen MJ; Liang XN; Yao RX; Shen B; Wu B; Li G; Sun YM; Wu JJ; Liu FT; Yang YJ; Wang J;
    J Parkinsons Dis; 2023; 13(1):83-91. PubMed ID: 36591660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale.
    Pantelyat A; Higginbotham L; Rosenthal L; Lanham D; Nesspor V; AlSalihi M; Bang J; Wang J; Albert M
    Neurodegener Dis; 2020; 20(4):139-146. PubMed ID: 33789283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
    Necpál J; Borsek M; Jeleňová B
    Neurol Sci; 2021 Dec; 42(12):4927-4936. PubMed ID: 34532773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in patients with progressive supranuclear palsy.
    Schrag A; Selai C; Davis J; Lees AJ; Jahanshahi M; Quinn N
    Mov Disord; 2003 Dec; 18(12):1464-9. PubMed ID: 14673883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis.
    Del Prete E; Tommasini L; Mazzucchi S; Frosini D; Palermo G; Morganti R; Pagni C; Tognoni G; Bonuccelli U; Ceravolo R
    Neurol Sci; 2021 Apr; 42(4):1483-1490. PubMed ID: 32851538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Italian version of the PSP Quality of Life questionnaire.
    Picillo M; Cuoco S; Amboni M; Bonifacio FP; Bruschi F; Carotenuto I; De Micco R; De Rosa A; Del Prete E; Di Biasio F; Elifani F; Erro R; Fabbri M; Falla M; Franco G; Frosini D; Galantucci S; Lazzeri G; Magistrelli L; Malaguti MC; Milner AV; Minafra B; Olivola E; Pilotto A; Rascunà C; Rizzetti MC; Schirinzi T; Borroni B; Ceravolo R; Di Fonzo A; Marchese R; Mercuri NB; Modugno N; Nicoletti A; Padovani A; Santangelo G; Stefani A; Tessitore A; Volontè MA; Zangaglia R; Zappia M; Zibetti M; Barone P
    Neurol Sci; 2019 Dec; 40(12):2587-2594. PubMed ID: 31350659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular autonomic dysfunction is associated with executive dysfunction and poorer quality of life in progressive supranuclear palsy-Richardson's syndrome.
    Liu P; Chen Y; Wang B; Wu S; Zeng L; Cen Z; Yang D; Wang H; Chen X; Wang L; Ouyang Z; Luo W
    J Clin Neurosci; 2022 Feb; 96():147-153. PubMed ID: 34789416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy.
    Picillo M; Cuoco S; Amboni M; Bonifacio FP; Bruno A; Bruschi F; Cappiello A; De Micco R; De Rosa A; Di Biasio F; Elifani F; Erro R; Fabbri M; Falla M; Franco G; Frosini D; Galantucci S; Lazzeri G; Magistrelli L; Malaguti MC; Milner AV; Minafra B; Olivola E; Pilotto A; Rascunà C; Rizzetti MC; Schirinzi T; Borroni B; Ceravolo R; Di Fonzo A; Lopiano L; Marchese R; Mercuri NB; Modugno N; Nicoletti A; Padovani A; Santangelo G; Stefani A; Tessitore A; Volontè MA; Zangaglia R; Zappia M; Barone P
    Neurol Sci; 2019 Oct; 40(10):2163-2169. PubMed ID: 31190253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
    Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
    Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
    Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.
    Quattrone A; Morelli M; Quattrone A; Vescio B; Nigro S; Arabia G; Nisticò R; Novellino F; Salsone M; Arcuri P; Luca A; Mazzuca A; Alessio C; Rocca F; Caracciolo M
    Parkinsonism Relat Disord; 2020 Mar; 72():1-6. PubMed ID: 32036297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicidal and death ideation in patients with progressive supranuclear palsy and corticobasal syndrome.
    Ou R; Wei Q; Hou Y; Zhang L; Liu K; Xu X; Gu X; Lin J; Jiang Z; Liu J; Song W; Cao B; Shang H
    J Affect Disord; 2020 Nov; 276():1061-1068. PubMed ID: 32768878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy.
    Tommasini L; Bonaccorsi J; Del Prete E; Cintoli S; Pagni C; Mazzucchi S; Palermo G; Morganti R; Frosini D; Siciliano G; Tognoni G; Ceravolo R
    Clin Neuropsychol; 2023 Aug; 37(6):1207-1220. PubMed ID: 35997036
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding fatigue in progressive supranuclear palsy.
    Ahn JH; Song J; Lee DY; Youn J; Cho JW
    Sci Rep; 2021 Aug; 11(1):16926. PubMed ID: 34413435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
    Gatto RG; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Dickson DW; Josephs KA; Whitwell JL
    Neuroimage Clin; 2022; 35():103030. PubMed ID: 35597031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.